Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected1M Return
Partial Period · Aug 3, 2026 — Sep 4, 2026
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | BIAF | MRNA |
|---|---|---|
| Return | ||
| Last Price | 15.27 | — |
| Daily Change | + 19.48% | — |
| Period ReturnPast Month | + 70.41%Aug 3, 2026 — Sep 4, 2026 | + 165.51% |
| Valuation | ||
| Market Cap | $3.24 M | $57.5 B |
| P/E Ratio | — | — |
| Dividend Yield | — | — |
| Net MarginTrailing 12M | 257.3% | — |
| Risk | ||
| Beta | -1.36 | — |
| 52-Week Range | 4.56 — $202.50 | — |
| Company | ||
| Sector | — | Health Care |
| Industry | Biotechnology | Biotechnology |
Company
- BIAFBiotechnology
- MRNAHealth Care · Biotechnology
Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 23:00
To Understand This